|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-5-12
|
|
pubmed:abstractText |
Discontinuation of growth hormone (GH) therapy on completion of linear growth may adversely affect bone mineral density (BMD) in young adults with childhood-onset GH-deficiency (GHD). In the present study, we analyzed the impact of GH treatment on bone in young adults with GHD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1479-683X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
899-907
|
|
pubmed:meshHeading |
pubmed-meshheading:19324976-Absorptiometry, Photon,
pubmed-meshheading:19324976-Adolescent,
pubmed-meshheading:19324976-Adult,
pubmed-meshheading:19324976-Age of Onset,
pubmed-meshheading:19324976-Alkaline Phosphatase,
pubmed-meshheading:19324976-Bone Density,
pubmed-meshheading:19324976-Bone Remodeling,
pubmed-meshheading:19324976-Bone and Bones,
pubmed-meshheading:19324976-Female,
pubmed-meshheading:19324976-Growth Disorders,
pubmed-meshheading:19324976-Human Growth Hormone,
pubmed-meshheading:19324976-Humans,
pubmed-meshheading:19324976-Insulin-Like Growth Factor I,
pubmed-meshheading:19324976-Male,
pubmed-meshheading:19324976-Recombinant Proteins,
pubmed-meshheading:19324976-Treatment Outcome,
pubmed-meshheading:19324976-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.
|
|
pubmed:affiliation |
Department of Endocrinology and Diabetes, University College London Hospitals, 250 Euston Road, London NW1 2PQ, UK. g.conway@ucl.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
